Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema
- 1 January 2008
- journal article
- review article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 100 (1), S7-S12
- https://doi.org/10.1016/s1081-1206(10)60580-7
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Biochemical Basis of Angioedema Associated With Recombinant Tissue Plasminogen Activator TreatmentStroke, 2002
- Angioedema induced by a peptide derived from complement component C2.The Journal of Experimental Medicine, 1988
- C1 Inhibitor and Hereditary Angioneurotic EdemaAnnual Review of Immunology, 1988
- Prekallikrein Activation and High-Molecular-Weight Kininogen Consumption in Hereditary AngioedemaNew England Journal of Medicine, 1983
- Detection of active kallikrein in induced blister fluids of hereditary angioedema patients.The Journal of Experimental Medicine, 1980
- Homozygous C3 deficiency: Detection of C3 by radioimmunoassayClinical Immunology and Immunopathology, 1977
- Kinin Formation in Hereditary Angioneurotic Edema (HANE) PlasmaInternational Archives of Allergy and Immunology, 1973
- Activation of plasminogen by human plasma kallikreinBiochemical and Biophysical Research Communications, 1969
- Effect of C′1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edemaJournal of Clinical Investigation, 1968
- Hereditary angioneurotic edema: II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikreinJournal of Allergy, 1962